Adapting to uncertainty over product review timelines at FDA could complicate M&A for pharma buyers and sellers, especially ...

Global private equity and venture capital investments in pharmaceutical companies lag 2024 figures, and regulatory headwinds ...

Drug prices in the United States are astronomical and climbing. Many analysts blame mergers and acquisitions among ...

The FDA’s recent activities regarding Covid-19 vaccines stray far from the well-established standards of vaccine regulatory ...

A BioSpace survey found that 56% of employed and 81% of unemployed respondents are considering jobs outside biopharma. Some ...

From a higher bar for regulatory clearance to pricing limitations, drug development is more expensive than ever. This has led ...

Manykandaprebou Vaitinadin has played a key role in leading such integrations, leveraging SAP's capabilities to optimize ...

The Pharma Quality Excellence Awards 2025 ceremony marked a significant milestone in recognizing outstanding contributions to pharmaceutical quality standards. Held in Hotel Westin Mumbai Garden City, ...

The Healthcare Engagement Strategy Awards 2012 show that the leaders in the pharmaceutical and healthcare industry are no longer lagging behind the rest of the world in their successful adoption ...

In this article, Christopher Ehinger questions whether rare diseases are a viable option for the pharma industry ... treatment in a specific country. A deviation of only 1 or 2 patients will ...

Another critical concern lies in the gap between the industry's technical demands and the available talent pool. Modern pharmaceutical manufacturing, especially in fields like biologics and ...

For the second year in a row, the pharmaceutical industry has dipped further out of favor with patient groups around the world. The industry’s reputation surged during the COVID-19 pandemic ...